Found 11 news articles for Inflammatory bowel disease (IBD)

Order by most

Recent Relevant
  • Flicking the inflammation off-switch

    In a long-term collaboration between researchers and industry, an exciting first step has been made in the creation of a new generation of medicines for auto-immune diseases using one of……  Read more

    A/Prof Claudia Nold and Professor Marcel Nold from The Ritchie Centre at Hudson Institute of Medical Research
  • State-of-the art genomic sequencer accelerates inflammation research

    Hudson Institute of Medical Research is progressing its genomic and inflammation research thanks to the support of the Victorian Government and The Ian Potter Foundation, who assisted with the acquisition……  Read more

    Dr Sam Forster and Professor Elizabeth Hartland using Illumina NextSeq2000
  • Rachel’s story | Living with Crohn’s disease

    Rachel Botros, 19, has suffered from Crohn’s disease since she was a 14-year-old. The chronic condition interrupted her schooling and ability to live a typical teenage life. Her two siblings……  Read more

    Rachel Botros, Crohns disease sufferer
  • Crohn’s disease in Australia – the latest research

    What is Crohn’s disease? Crohn’s is an inflammatory disease which affects the gastrointestinal (GI) tract. It is incurable and usually chronic with periods of flare ups lasting anywhere from a……  Read more

    Dr Edward Giles a Senior Research Scientist in the Regulation of Interferon and Innate Signalling group at Hudson Institute
  • NHMRC Ideas Grants success

    Hudson Institute has been successful in the NHMRC Ideas Grant round. Our researchers have been awarded four NHMRC Ideas Grants, totalling almost $4.1 million. Ideas Grants fund innovative and creative……  Read more

    Sam, Paul, Ed and Vince, Hudson Institute's successful NHMRC Ideas Grants recipients
  • Crohn’s disease diagnosis impacts future health

    Crohn’s disease is an incurable inflammatory bowel disease (IBD) affecting more than 60,000 Australians, including children. Dr Edward Giles With effective treatment many children remain symptom-free for long periods of……  Read more

    Edward Giles from the Regulation of Interferon and Innate Signalling Research Group at Hudson Institute
  • Paving the way towards a new anti-inflammatory agent

    Hudson Institute researchers provide new insights into how the IL-37 protein blocks inflammation—emphasising the potential for a novel treatment in the fight against a plethora of inflammatory diseases. IL-37 is……  Read more

    Dr Ina Rudloff, Postdoctoral Scientist in the Interventional Immunology in Early Life Diseases Research Group at Hudson Institute
  • NHMRC Ideas Grant success

    Hudson Institute has had outstanding success in the NHMRC Ideas Grant round. Our researchers have been awarded nine NHMRC Ideas Grants, totalling almost $8.5 million. Ideas Grants fund innovative and……  Read more

  • NHMRC Fellowship success

    Hudson Institute has had outstanding success in the recent National Health and Medical Research Council (NHMRC) Fellowship and Development Grant announcements. Our researchers have been awarded a total of $5,337,790……  Read more

    Associate Professor Rebecca Lim, 2017 NHMRC Grant success
  • Stunning NHMRC Grant success

    Hudson Institute has had outstanding success in the recent NHMRC Project Grant round. Our researchers have been awarded $14.8 million for 19 new NHMRC Project Grants to work on colorectal……  Read more

    Professor Marcel Nold and A/Professor Claudia Nold from Hudson Institute of Medical Research